Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Trimetrexate

Product Specifications

UNSPSC Description

Trimetrexate (CI-898) is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR. Trimetrexate can also inhibit the growth of various cancer cells. Trimetrexate can be used for researching Pneumocystis carinii pneumonia (PCP) and cancer[1][2][3][4][5].

Target Antigen

Antibiotic; Antifolate; Bacterial; Dihydrofolate reductase (DHFR) ; DNA/RNA Synthesis; Parasite

Type

Reference compound

Related Pathways

Anti-infection;Cell Cycle/DNA Damage;Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/Trimetrexate.html

Purity

99.22

Solubility

DMSO : ≥ 61.5 mg/mL

Smiles

NC1=C(C(C)=C2CNC3=CC(OC)=C(OC)C(OC)=C3)C(C=C2)=NC(N)=N1

Molecular Weight

369.42

References & Citations

[1]Fulton, B., et al. Trimetrexate. Drugs 49, 563–576 (1995).|[2]Hopper AT, et al. Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis. J Med Chem. 2019 Feb 14;62(3):1562-1576.|[3]Allegra CJ, et al. Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. J Clin Invest. 1987 Feb;79(2):478-82.|[4]Dethloff LA, et al. Chronic toxicity of the anticancer agent trimetrexate in rats. Fundam Appl Toxicol. 1992 Jul;19(1):6-14.|[5]Grem JL, Voeller DM, Geoffroy F, Horak E, Johnston PG, Allegra CJ. Determinants of trimetrexate lethality in human colon cancer cells. Br J Cancer. 1994 Dec;70(6):1075-84.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-10373/Trimetrexate-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-10373/Trimetrexate-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

52128-35-5

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

BRCA2 (NM_000059) Human Mutant ORF Clone
RC400689 10 µg

BRCA2 (NM_000059) Human Mutant ORF Clone

Ask
View Details
Recombinant Human TP53-binding protein 1 (C-His)
BP2824-500ug 500 µg

Recombinant Human TP53-binding protein 1 (C-His)

Ask
View Details
Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)
MBS1006068-01 0.02 mg (E-Coli)

Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)

Ask
View Details
Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)
MBS1006068-02 0.02 mg (Yeast)

Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)

Ask
View Details
Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)
MBS1006068-03 0.1 mg (E-Coli)

Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)

Ask
View Details
Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)
MBS1006068-04 0.1 mg (Yeast)

Recombinant Escherichia coli 3-dehydroquinate synthase (aroB)

Ask
View Details